Dimebon (latrepirdine) an investigational drug to treat Alzheimer's disease failed in late phase clinical studies, Pfizer Inc and Medivation, Inc, the developers of the drug which was thought to be promising lead, announced.

Abbott and its research partner Enanta Pharmaceuticals will start clinical studies to evaluate three antiviral agents to hepatitis C (HCV) infection.

Aurobindo Pharma, a leading APIs and generic formulations maker from India, has secured marketing approval for cefuroxime antibiotic pills in Canada, the company announced.

Panacea Biotec has entered into an advance marketing agreement with Ministry of Health and Family Welfare (MoHWF) for supplying its H1N1 swine flu vaccine Pandyflu.

US FDA has denied approval for Daiichi-Ranbaxy's generic tamsulosin hydrochloride tablets to treat  enlarged prostate due to the ongoing controversy on good manufacturing practice norms violations, reports said.

Government of India has drawn up a plan to effectively review and monitor the way stem cell research being conducted in the country, according to reports.